These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 9101356)
1. Renal metastasis. Detection and characterization on enhanced magnetic resonance imaging using an animal model. Runge VM; Wells JW; Williams NM Invest Radiol; 1997 Apr; 32(4):212-7. PubMed ID: 9101356 [TBL] [Abstract][Full Text] [Related]
2. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881 [TBL] [Abstract][Full Text] [Related]
3. Detectability of small liver metastases with gadolinium BOPTA. Runge VM; Lee C; Williams NM Invest Radiol; 1997 Sep; 32(9):557-65. PubMed ID: 9291044 [TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced magnetic resonance imaging in a spinal epidural tumor model. Runge VM; Lee C; Iten AL; Williams NM Invest Radiol; 1997 Oct; 32(10):589-95. PubMed ID: 9342117 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of experimental pyelonephritis in rabbits. Runge VM; Timoney JF; Williams NM Invest Radiol; 1997 Nov; 32(11):696-704. PubMed ID: 9387058 [TBL] [Abstract][Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging in a model of splenic metastasis. Runge VM; Williams NM Invest Radiol; 1998 Jan; 33(1):45-50. PubMed ID: 9438509 [TBL] [Abstract][Full Text] [Related]
7. Early dynamic magnetic resonance imaging of liver metastases with 0.3 and 0.6 mmol/kg gadoteridol injection. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Aug; 31(8):472-8. PubMed ID: 8854193 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of standard and high-dose contrast-enhanced breath-hold liver magnetic resonance for visualization of metastatic disease in an animal model. Runge VM Invest Radiol; 1998 May; 33(5):263-7. PubMed ID: 9609484 [TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging in a spinal abscess model. Preliminary report. Runge VM; Williams NM; Lee C; Timoney JF Invest Radiol; 1998 Apr; 33(4):246-55. PubMed ID: 9556750 [TBL] [Abstract][Full Text] [Related]
10. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement. Kim TK; Choi BI; Han JK; Jang HJ; Han MC Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360 [TBL] [Abstract][Full Text] [Related]
12. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease. Runge VM; Wells JW; Williams NM Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188 [TBL] [Abstract][Full Text] [Related]
13. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. Tang Y; Yamashita Y; Arakawa A; Namimoto T; Mitsuzaki K; Abe Y; Katahira K; Takahashi M AJR Am J Roentgenol; 1999 Jun; 172(6):1547-54. PubMed ID: 10350287 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of an experimental model of intracranial metastatic disease. A study of lesion detectability. Runge VM; Wells JW; Williams NM Invest Radiol; 1994 Dec; 29(12):1050-6. PubMed ID: 7721546 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of cerebral diseases: how much contrast agent is enough? Comparison of 0.1, 0.2, and 0.3 mmol/kg gadoteridol at 0.2 T with 0.1 mmol/kg gadoteridol at 1.5 T. Brekenfeld C; Foert E; Hundt W; Kenn W; Lodeann KP; Gehl HB Invest Radiol; 2001 May; 36(5):266-75. PubMed ID: 11323514 [TBL] [Abstract][Full Text] [Related]